Adamis Pharmaceuticals is Pharmaceuticals in United States that focus on Adamis Pharmaceuticals Corp business. Founded in 2006. They cover business area such as Adamis Pharmaceuticals Corp, product, various therapeutic area, allergy, opioid overdose, respiratory and inflammatory disease, SYMJEPI, epinephrine, injection, Injection, mg, use, acute allergic reaction, anaphylaxis, ZIMHI, Tempol, an investigational drug, asthma.
2006
( 18 years old in 2024 )
Adamis Pharmaceuticals Corp
-
11682 El Camino Real
Suite 300
San Diego, CA 92130
United States
Private
Adamis Pharmaceuticals Corpproductvarious therapeutic areaallergyopioid overdose, respiratory and inflammatory diseaseSYMJEPIepinephrineinjectionInjectionmguseacute allergic reactionanaphylaxisZIMHITempolan investigational drugasthma
* We use standard office opening hours in near Adamis Pharmaceuticals's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Adamis Pharmaceuticals is Pharmaceuticals business from United States that founded in 2006 (18 years old in 2024), Adamis Pharmaceuticals business is focusing on Adamis Pharmaceuticals Corp.
Adamis Pharmaceuticals headquarter office and corporate office address is located in 11682 El Camino Real Suite 300 San Diego, CA 92130 United States.
Adamis Pharmaceuticals was founded in United States.
In 2024, Adamis Pharmaceuticals is currently focus on Adamis Pharmaceuticals Corp sector.
Above is snippet of Google Trends for "Adamis Pharmaceuticals Corp" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Adamis Pharmaceuticals, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
